Short answer · Medically reviewed summary · Last updated: 2026-04-08
TL;DR: Pulmonary atresia is a congenital heart defect caused by the failure of the pulmonary valve to develop properly during fetal heart formation, preventing blood from flowing from the heart to the lungs. While the exact cause remains largely unknown in most cases, it is considered a multifactorial condition resulting from a complex interplay between genetic predispositions and environmental influences during early pregnancy. What causes Pulmonary atresia to develop in a fetus? Pulmonary atresia occurs during the first eight weeks of embryonic development.
TL;DR: Pulmonary atresia is a congenital heart defect caused by the failure of the pulmonary valve to develop properly during fetal heart formation, preventing blood from flowing from the heart to the lungs. While the exact cause remains largely unknown in most cases, it is considered a multifactorial condition resulting from a complex interplay between genetic predispositions and environmental influences during early pregnancy.
Pulmonary atresia occurs during the first eight weeks of embryonic development. In a healthy heart, the pulmonary valve acts like a one-way gate, allowing blood to travel from the right ventricle into the pulmonary artery toward the lungs. In a fetus with Pulmonary atresia, this valve fails to form an opening, remaining solid or "atretic." Because blood cannot pass through this valve, the heart must find alternative pathways to circulate blood to the lungs, often relying on existing fetal structures like the ductus arteriosus that usually close shortly after birth. In the 31 members of our DiseaseMaps community who have navigated this diagnosis, this developmental error is the central challenge that defines their journey.
While most cases of Pulmonary atresia occur sporadically without a clear family history, genetic factors play a significant role. Research suggests that chromosomal abnormalities, such as 22q11.2 deletion syndrome (DiGeorge syndrome), are associated with an increased risk of various congenital heart defects, including Pulmonary atresia. Geneticists believe that mutations in specific genes governing heart development—such as NKX2-5 or GATA4—may disrupt the delicate signaling required for the pulmonary valve to open correctly. However, these genetic markers are not present in every patient, indicating that the condition is rarely the result of a single "faulty" gene.
It is important to distinguish between causes—the direct biological mechanism—and risk factors, which are conditions that may increase the likelihood of the defect occurring. While we cannot always pinpoint a single trigger, clinical research has identified several factors that may impact cardiac development:
Currently, the exact etiology of Pulmonary atresia is not fully understood. Medical researchers are actively investigating the molecular pathways of "cardiac looping," the process by which the heart tube folds into a four-chambered organ. Ongoing studies are utilizing advanced genomic sequencing to better understand why the pulmonary valve fails to perforate. By mapping the experiences of our 31 community members and others globally, researchers hope to identify common patterns that could eventually lead to earlier prenatal detection and improved surgical interventions for Pulmonary atresia.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.